Press "Enter" to skip to content

New patent for Astrazeneca drug LYNPARZA

0
Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca drug LYNPARZA

Annual Drug Patent Expirations for LYNPARZA
Annual Drug Patent Expirations for LYNPARZA

Lynparza is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eleven patents protecting this drug.

This drug has two hundred and fifty-two patent family members in fifty countries.

The generic ingredient in LYNPARZA is olaparib. One supplier is listed for this compound. Additional details are available on the olaparib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca drug LYNPARZA
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    DrugPatentWatch - Make Better Decisions